Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation.
The report details the trend, potential and market size of Lubiprostone market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Lubiprostonemarket, defines the market attractiveness level of Lubiprostone market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Lubiprostone industry, describes the types of Lubiprostone market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lubiprostone market and the development prospects and opportunities of Lubiprostone industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lubiprostone market in Chapter 13.
By Player:
Takeda Pharmaceuticals
By Type:
8 mcg Capsules
24 mcg Capsules
By End-User:
CIC and OIC
IBS-C
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Lubiprostone Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Lubiprostone Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Lubiprostone Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Lubiprostone Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Lubiprostone Market Analysis and Outlook to 2022
-
7.1 Global Lubiprostone Consumption (2017-2022)
-
7.2 United States Lubiprostone Consumption (2017-2022)
-
7.3 Europe Lubiprostone Consumption (2017-2022)
-
7.4 China Lubiprostone Consumption (2017-2022)
-
7.5 Japan Lubiprostone Consumption (2017-2022)
-
7.6 India Lubiprostone Consumption (2017-2022)
-
7.7 South Korea Lubiprostone Consumption (2017-2022)
8 Region and Country-wise Lubiprostone Market Analysis and Outlook to 2028
-
8.1 Global Lubiprostone Consumption Forecast (2022-2028)
-
8.2 United States Lubiprostone Consumption Forecast (2022-2028)
-
8.3 Europe Lubiprostone Consumption Forecast (2022-2028)
-
8.4 China Lubiprostone Consumption Forecast (2022-2028)
-
8.5 Japan Lubiprostone Consumption Forecast (2022-2028)
-
8.6 India Lubiprostone Consumption Forecast (2022-2028)
-
8.7 South Korea Lubiprostone Consumption Forecast (2022-2028)
9 Global Lubiprostone Market Outlook by Types and Applications to 2022
-
9.1 Global Lubiprostone Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 8 mcg Capsules Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 24 mcg Capsules Consumption and Growth Rate (2017-2022)
-
9.2 Global Lubiprostone Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global CIC and OIC Consumption and Growth Rate (2017-2022)
-
9.2.2 Global IBS-C Consumption and Growth Rate (2017-2022)
10 Global Lubiprostone Market Outlook by Types and Applications to 2028
-
10.1 Global Lubiprostone Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 8 mcg Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 24 mcg Capsules Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Lubiprostone Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global CIC and OIC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global IBS-C Consumption Forecast and Growth Rate (2022-2028)
11 Global Lubiprostone Import and Export Analysis (Top 5 Countries)
-
11.1 Global Lubiprostone Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Lubiprostone Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Lubiprostone Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Lubiprostone Market Competitive Analysis
-
14.1 Takeda Pharmaceuticals
-
14.1.1 Takeda Pharmaceuticals Company Details
-
14.1.2 Takeda Pharmaceuticals Lubiprostone Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda Pharmaceuticals Lubiprostone Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Lubiprostone
-
Figure Lubiprostone Picture
-
Table Global Lubiprostone Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lubiprostone Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lubiprostone Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Lubiprostone Consumption by Country (2017-2022)
-
Figure United States Lubiprostone Consumption and Growth Rate (2017-2022)
-
Table Europe Lubiprostone Consumption and Growth Rate (2017-2022)
-
Figure China Lubiprostone Consumption and Growth Rate (2017-2022)
-
Figure Japan Lubiprostone Consumption and Growth Rate (2017-2022)
-
Figure India Lubiprostone Consumption and Growth Rate (2017-2022)
-
Figure South Korea Lubiprostone Consumption and Growth Rate (2017-2022)
-
Figure Global Lubiprostone Consumption Forecast by Country (2022-2028)
-
Figure United States Lubiprostone Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Lubiprostone Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Lubiprostone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Lubiprostone Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Lubiprostone Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Lubiprostone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 8 mcg Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global 24 mcg Capsules Consumption and Growth Rate (2017-2022)
-
Figure Global CIC and OIC Consumption and Growth Rate (2017-2022)
-
Figure Global IBS-C Consumption and Growth Rate (2017-2022)
-
Figure Global 8 mcg Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 24 mcg Capsules Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CIC and OIC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IBS-C Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Lubiprostone Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Lubiprostone Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceuticals Lubiprostone Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceuticals Lubiprostone Product and Service
-
